Novo Nordisk
NVO
NVO
510 hedge funds and large institutions have $7.76B invested in Novo Nordisk in 2016 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 190 increasing their positions, 186 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
510
Holders Change
-18
Holders Change %
-3.41%
% of All Funds
13.63%
Holding in Top 10
14
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-41.67%
% of All Funds
0.37%
New
42
Increased
190
Reduced
186
Closed
54
Calls
$14.1M
Puts
$29M
Net Calls
-$14.9M
Net Calls Change
-$15.4M
Top Buyers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$139M |
| 2 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$77.3M |
| 3 |
Renaissance Technologies
New York
|
+$70.9M |
| 4 |
Morgan Stanley
New York
|
+$58.9M |
| 5 |
Millennium Management
New York
|
+$56.7M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$457M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$273M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$134M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$86M |
| 5 |
Lazard Asset Management
New York
|
-$65.9M |
